Start-up NextImmune supported by Venture Kick
Development of selective immunosuppressive drugs
05-Jul-2022 -
NextImmune, a spin-off from the Biozentrum of the University of Basel, has received financial support of 150,000 Swiss francs from the Venture Kick funding initiative. The start-up develops a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation.
The company ...
autoimmune diseases
funding
immunosuppressants
+1